A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

NCT07165223 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: GZR4
DRUG: Insulin Icodec group

Sponsor

Gan & Lee Pharmaceuticals.